Source / episode info
- **Episode:**25
- **Title:**Divine Intervention Episode 25 – Autonomic Pharmacology Part 3.
- **Published:**2018-04-30
- Source:Episode page
One-liner
This episode reviews autonomic pharmacology by detailing cholinergic crisis management (organophosphates), diagnosing Myasthenia Gravis with AChE inhibitors, utilizing muscarinic agonists and antagonists for specific conditions like glaucoma and asthma, and differentiating pharmacological treatments for the three types of urinary incontinence.
High-yield summary
- Cholinergic Crisis: Caused by excessive acetylcholine (e.g., organophosphates). Treatment involves an anticholinergic agent (atropine) to block muscarinic receptors AND a cholinesterase inhibitor (pridostigmine) to boost ACh levels and outcompete the toxin.
- Myasthenia Gravis (MG): Pathophysiology involves autoantibodies against the nicotinic acetylcholine receptor ({AChR}). Diagnosis is confirmed by detecting anti-{AChR} antibodies; treatment uses {AChE} inhibitors (pyridostigmine, neostigmine) to increase synaptic ACh.
- Muscarinic Agonists: Used for conditions like dry mouth (Sjögren's syndrome) or angle-closure glaucoma. Examples include pilocarpine and cevilastine.
- Incontinence Treatment Triad: The treatment depends on the underlying pathophysiology: 1) Urge Incontinence -> Muscarinic Antagonist (e.g., Oxybutynin); 2) Overflow Incontinence -> Muscarinic Agonist (e.g., Bethanechol); 3) Straining/SUI -> Behavioral therapy (Kegel exercises).
- Vascular Tone: Alpha blockers (Phenoxybenzamine) are used for pheochromocytoma; Beta agonists (Norepinephrine) are preferred over pure alpha agonists in septic shock due to their balanced action.
Learning objectives
- Differentiate between muscarinic and nicotinic receptor pharmacology and their clinical applications.
- Recognize the pathophysiology, diagnosis, and management of Myasthenia Gravis and cholinergic poisoning.
- Apply pharmacological principles to manage different types of urinary incontinence (urge vs. overflow).
- Understand the sequential blockade required for pheochromocytoma management (\alpha_1 before \beta).
- Select appropriate muscarinic agonists/antagonists based on specific glandular or organ function deficits (e.g., glaucoma, OAB).
Board exam buzzwords